Por: The New York Times Science October 11, 2023
Scientists have used the gene-editing technology known as CRISPR to create chickens that have some resistance to avian influenza, according to that was published in the journal Nature Communications on Tuesday.The study suggests that genetic engineering could potentially be one tool for reducing the toll of bird flu, a group of viruses that pose grave dangers to both animals and humans. But the study also highlights the limitations and potential... + full article
RTTNews USA Health September 01, 2023
CRISPR Therapeutics (), a gene editing company developing gene-based medicines for serious diseases, is scheduled to participate in a fireside chat at Citi's 18th Annual Biopharma Conference on September 6.Exa-cel, formerly known as CTX001, an investigational, autologous,... + más
Vor Biopharma says first patient given its gene editing therapy for leukemia is in remission | The Boston Globe
Opinion | The New York Times
The Atlantic USA Science May 24, 2023
Polynesians brought chickens’ wild ancestors to the islands. Europeans brought domestic chickens. Now they’ve mixed, and are everywhere.Cory Lum / NYT / ReduxMay 24, 2023, 8 AM ETOn the island of Kauai, wherever humans go, chickens go too. Hens and chicks kick around in... + más
Feral cows to be gunned down by shooters in helicopters in US national forest | ABC News
Feral cattle roam New Mexico wilderness. Federal agents plan to hunt them from the sky | Los Angeles Times
The New York Times USA Opinion December 09, 2022
The parents of a 2-year-old girl write that their daughter “could die within the next year” because a genetic mutation is causing her heart to fail.“Time is quickly running out for me,” writes a man in his mid-30s whose DNA harbors a genetic mistake certain to destroy... + más
Justice Alito accused of being SCOTUS leaker after new report: Disgrace | Newsweek
Why would Mac Jones get a second opinion on his injury, and how common is that? | The Boston Globe
The Boston Globe USA Business December 07, 2022
A Cambridge biotech company using to develop therapies for blood cancers said that its experimental treatment for acute myeloid leukemia proved safe in the first recipient, who is currently in remission.The preliminary results, announced Wednesday morning, were a long time... + más
Boston startup Ascidian Therapeutics charts vision for therapies that ‘rewrite RNA’ | The Boston Globe
New York Post USA Life November 11, 2022
Those living with cancer may soon be eligible for the most bespoke treatment to date. New research has the potential to revolutionize the battle against cancer by “editing” patients’ own cells to fight their unique disease profile. As part of a clinical trial, published in... + más
Personalized cancer treatment edges closer with CRISPR trial success | Newsweek
Ars Technica USA Science October 06, 2022
Navigate Filter by topic Settings Front page layout Site theme Comment activity Sign up or login to join the discussions! Sign up to comment and more - Oct 6, 2022 12:00 pm UTC / A 3D illustration of the HIV virus. Share this story In July, an HIV-positive man became the first... + más
Starting a Revolution Isn’t Enough | The Atlantic
HIV-positive people who have monkeypox are hospitalized more often, CDC study says | CNBC
The Atlantic USA Science September 24, 2022
CRISPR is changing the world—but it can do more.Erik Carter / The AtlanticSeptember 12, 2022Two years ago, I was working on my laptop in an airport lounge in Newark, New Jersey, when I glanced up and saw a couple walking with their two boys. The younger boy slowly made his way... + más
Teenagers on Revolution roster have provided a spark that bodes well for the future | The Boston Globe
‘I Think the Women Are Winning’ | The Atlantic
About iurex | Privacy Policy | Disclaimer |